Skip to content

Tailored Interventions to Improve Hypertension Management After Stroke or Transient Ischemic Attack (TIA)

Tailored Interventions to Improve Hypertension Management After Stroke or TIA

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01038375
Acronym
TIMSII
Enrollment
56
Registered
2009-12-23
Start date
2010-03-31
Completion date
2011-10-31
Last updated
2012-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Keywords

hypertension, stroke, adherence

Brief summary

The purpose of this study is to determine the effectiveness of interventions to improve adherence to medication and healthier lifestyle choices on blood pressure over a 6 month period in a group of people at high risk for recurrent stroke events. The participants have already had a stroke or TIA, and have uncontrolled blood pressure, as well as problems with memory and problem-solving, or miss taking medications, or who do not believe in the effectiveness of their medications. Interventions focus on motivational interviewing, adherence counseling with memory cuing, and self-monitoring of blood pressure.

Detailed description

* randomized, controlled trial at 4 sites * measurement of blood pressure, missed pills, self-efficacy rating at baseline and 6 months * contacting family pharmacists to evaluate prescription renewal patterns at baseline and 6 months

Interventions

BEHAVIORALlifestyle counseling, home blood pressure monitoring

monthly telephone counseling over 6 months for intervention group no health provider initiated contact for control group

Sponsors

Heart and Stroke Foundation of Ontario
CollaboratorOTHER
Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of stroke or TIA * hypertension * Montreal Cognitive Assessment score less than 26 * self report of missed pills * self-efficacy rating less than 100%

Exclusion criteria

* inability to give informed consent * 18 years of age or younger

Design outcomes

Primary

MeasureTime frame
blood pressure6 months from baseline testing

Secondary

MeasureTime frame
self-efficacy rating6 months from baseline

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026